| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.009 | 54.135 | 24.379 | 40.394 | 21.989 | 11.844 | 14.901 | 15.792 | 16.669 | 10.334 |
| Total Income - EUR | 54.274 | 55.927 | 24.517 | 40.435 | 22.037 | 11.867 | 14.917 | 15.854 | 16.710 | 13.233 |
| Total Expenses - EUR | 32.980 | 26.042 | 21.426 | 30.066 | 31.460 | 10.047 | 9.730 | 10.808 | 10.120 | 14.294 |
| Gross Profit/Loss - EUR | 21.293 | 29.885 | 3.091 | 10.369 | -9.423 | 1.820 | 5.187 | 5.046 | 6.590 | -1.060 |
| Net Profit/Loss - EUR | 19.600 | 28.803 | 2.847 | 9.966 | -9.643 | 1.708 | 5.041 | 4.911 | 6.214 | -1.060 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Biodova Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 33.364 | 35.494 | 21.486 | 29.194 | 28.959 | 24.292 | 21.349 | 24.447 | 19.702 | 14.004 |
| Inventories | 12.116 | 14.956 | 16.225 | 23.262 | 16.733 | 18.063 | 16.788 | 17.485 | 17.553 | 6.665 |
| Receivables | 6.509 | 1.021 | 511 | 586 | 764 | 658 | 615 | 850 | 737 | 1.882 |
| Cash | 14.739 | 19.516 | 4.750 | 5.346 | 11.462 | 5.571 | 3.946 | 6.112 | 1.412 | 5.456 |
| Shareholders Funds | 29.670 | 29.222 | 3.116 | 10.231 | -4.772 | -2.973 | 2.134 | 7.052 | 13.245 | 12.110 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.830 | 6.272 | 18.370 | 18.963 | 33.731 | 27.265 | 19.215 | 17.399 | 6.457 | 1.893 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Biodova Company Srl